UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | H | O | P | S | T | Z
Number of items: 11.


Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Batter, V; Coleman, R; Piccart, M; (2002) Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. Breast Cancer Research and Treatment , 76 138 - ?.


Baselga, J; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, DG; Kaye, SB; (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J CLIN ONCOL , 20 (21) 4292 - 4302. 10.1200/JCO.2002.03.100.

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Boddy, AV; Todd, R; Verrill, M; Sludden, J; Fishwick, K; Robson, L; Cassidy, J; (2002) Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study. European Journal of Cancer , 38 98 - ?.


Hughes, A; Calvert, P; Azzabi, A; Plummer, R; Johnson, R; Rusthoven, J; Griffin, M; (2002) Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J CLIN ONCOL , 20 (16) 3533 - 3544. 10.1200/JCO.2002.10.073.


Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; Pearce, W; (2002) Impaired B and T cell antigen receptor signaling in p110 delta PI 3-kinase mutant mice. SCIENCE , 297 (5583) pp. 1031-1034.


Panaretou, B; Siligardi, G; Meyer, P; Maloney, A; Sullivan, JK; Singh, S; Millson, SH; (2002) Activation of the ATPase activity of Hsp90 by the stress-regulated cochaperone Aha1. MOLECULAR CELL , 10 (6) pp. 1307-1318. 10.1016/S1097-2765(02)00785-2.

Pinto, M; (2002) Induction and rejoining of DNA double-strand breaks in human cells after exposure to ionising radiation: an experimental and modelling approach. Doctoral thesis, University of London. Green open access


Simpson, AB; Calvert, PM; Sludden, JA; Boddy, AV; Griffin, MJ; Schatzlein, A; Wilson, P; (2002) Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules. ANN ONCOL , 13 (3) 399 - 402. 10.1093/annonc/mdf041.


Thomas, HD; Porter, DJ; Bartelink, I; Nobbs, JR; Cole, M; Elliott, S; Newell, DR; (2002) Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide. BRIT J CLIN PHARMACO , 53 (1) 83 - 91.


Zhang, J; Vanhaesebroeck, B; Rittenhouse, SE; (2002) Human platelets contain p110 delta phosphoinositide 3-kinase. BIOCHEM BIOPH RES CO , 296 (1) 178 - 181.

This list was generated on Sun Oct 23 03:29:37 2016 BST.